Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Min Lang has a total of 203 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prism: A Multimodal XR Assistant for Spatial Imaging Workflows in Interventional Radiology

    by Chung-Ta Huang, Ezekiel D’AScoli, Binyan Xu, Jenny Wang, Raul N. Uppot, Min Lang

  • Clinical Validation of Deep Learning–Accelerated versus Wave-CAIPI Postcontrast 3D T1-MPRAGE for Evaluation of Intracranial Enhancing Lesions

    by Azadeh Tabari, Maryam Vejdani-Jahromi, Min Lang, Dominik Nickel, Wei-Ching Lo, Bryan Clifford, John Conklin, Susie Y. Huang

    Deep learning (DL) reconstruction methods have shown promise in accelerating 2D MRI sequences but have yet to be extensively validated for routine 3D volumetric MRI applications. Our purpose was to assess the diagnostic quality of a novel DL-accelerated 3D T1-MPRAGE compared with a state-of-the-art wave-controlled aliasing in parallel imaging (Wave-CAIPI) accelerated 3D T1-MPRAGE for evaluating intracranial enhancing lesions. This prospective study was approved by the Institutional Review Board. Patients undergoing contrast-enhanced brain MRI in an outpatient setting were scanned on 3T MRI systems. The imaging protocol included a state-of-the-art Wave-CAIPI postcontrast T1-MPRAGE (acceleration factor [R] = 2 × 2, acquisition time [TA] = 2:11 minutes) and a research-based postcontrast DL-T1-MPRAGE (R = 2 × 2, TA = 2:11 minutes). The DL-based reconstruction process involved 2 steps. The first step, inspired by variational networks, involved 6 iterations alternating between data consistency updates and neural network evaluation. The second step applied a super-resolution algorithm for further image enhancement. Two independent neuroradiologists conducted a blinded, randomized head-to-head comparison of the 2 sequences by using a previously published scale across the following criteria: visualization of dural, parenchymal, leptomeningeal, and ependymal enhancement; sharpness; noise; artifacts; and overall diagnostic quality. A third board-certified neuroradiologist adjudicated cases with discrepant ratings. Noninferiority of DL-T1-MPRAGE was tested by using a 15% margin. A total of 115 patients (68 women/47 men, mean age = 54 ± 10 years) were included. The top 3 clinical indications were: neoplasm (52%), vascular lesions (24%), and headache (8%). DL-T1-MPRAGE was noninferior to Wave-CAIPI T1-MPRAGE for delineating enhancing lesions with unanimous agreement in all cases with enhancing pathology. It was also noninferior in terms of noise perception (P < .0001), artifact (P < .0001), sharpness (P = .001), and overall diagnostic quality (P < .0001). DL-T1-MPRAGE provided equivalent visualization of small, subtle enhancing parenchymal, dural, and leptomeningeal lesions. The highly accelerated postcontrast DL-T1-MPRAGE demonstrated noninferior image quality compared with the clinically validated Wave-CAIPI T1-MPRAGE accelerated sequence while offering enhanced visualization of subtle enhancing lesions.

  • Clinical evaluation of scout accelerated motion estimation and reduction (SAMER) for brain MRI in non-sedated children: initial clinical experience

    by Azadeh Tabari, Komal Manzoor, Min Lang, Daniel Polak, Daniel Nicolas Splitthoff, Bryan Clifford, Wei-Ching Lo, Stephen Cauley, John Conklin, Michael S. Gee, et al.

    Background The scout accelerated motion estimation and reduction (SAMER) method has been developed to achieve rapid retrospective motion correction and may be advantageous in pediatric imaging to mitigate motion artifacts. Objective To evaluate the efficacy of SAMER for motion correction of brain imaging in awake pediatric patients. Methods In this institutional review board (IRB) approved and Health Insurance Portability and Accountability Act (HIPAA) compliant prospective study, 33 pediatric patients were scanned on a 3-T MRI system in the outpatient setting. The imaging protocol included an accelerated 3D T1-weighted SAMER MPRAGE research sequence acquired in 2 min 37 s. Retrospective reconstructions of the T1-weighted MPRAGE data were performed with and without SAMER motion correction. Reconstructed image pairs were reviewed side-by-side by two board-certified neuroradiologists in a blinded manner and graded for motion artifacts using a 5-point scale. The improvement in motion score was calculated by subtracting the post-correction score from the pre-correction score. Results Without SAMER motion correction, 24 out of 33 cases (73%) showed motion artifact (21% (7/33) minimal, 27%(9/33) mild, 9% (3/33) moderate, and 15% (5/33) severe). SAMER motion correction improved motion artifacts in 79% (19/24) of cases, improving the motion score by median of 3 vs. 2 for motion-corrected examinations using SAMER. After applying SAMER motion correction, 50% (4/8) of cases considered nondiagnostic due to motion were reclassified as diagnostic. Conclusion SAMER demonstrates potential for reducing motion artifacts in 3D T1-weighted MPRAGE brain MR images, with the most notable improvements occurring in cases of moderate to severe motion.


  • Open Access

    A 3-Minute Ultrafast MRI and MRA Protocol for Screening of Acute Ischemic Stroke

    by Maria Camila Cortes-Albornoz, Bryan Clifford, Wei-Ching Lo, Seonghwan Yee, Brooks P. Applewhite, Azadeh Tabari, Claire White-Dzuro, Stephen F. Cauley, Pamela W. Schaefer, Otto Rapalino, et al.


  • The Utilization of Blockchain for Data Security for the Chronic Pain Physician

    by Jordan Kruger, John Vernaleo, Dominic Mann, Min Lang, Jaya Pokuri, Zwade Marshall, Christopher L. Robinson

    Purpose of Review The COVID-19 pandemic accelerated the surge in medical data utilization, notably impacting chronic pain management given its enormous economist cost. While the collection and use of data enhances research and care quality, data exchange risks compromising integrity and privacy, exemplified by the Change Healthcare cyberattack. Here, we review the potential of blockchain for the utilization for cybersecurity in the healthcare system with an emphasis on the field of chronic pain. Recent Findings Blockchain technology emerges as a potential solution, offering decentralized, secure, and immutable data management. Blockchain ensures transparency, integrity, and data privacy, which is crucial in healthcare. Smart contracts may offer automated, secure management of implantable neuromodulation devices such as spinal cord stimulators and intrathecal pumps. Blockchain’s potential in pharmaceutical supply chain integrity is exemplified in preliminary efforts ensuring that the medication retrieved by the patient is indeed the intended medication. Summary Despite limitations such as speed of transactions, blockchain presents innovative avenues for healthcare security and quality improvement, necessitating further development for widespread implementation. Blockchain’s applicability is not only applicable to chronic pain management, but can be used in medicine as a whole.


  • Noncontrast MRI Surveillance of Craniopharyngiomas Using a Balanced Steady-state Free Precession (bSSFP) Sequence

    by Kelly Trinh, Michael Tang, Claire White-Dzuro, Min Lang, Karen Buch, Sandra Rincon

    BACKGROUND AND PURPOSE: Contrast-enhanced MRI (CEMRI) is a commonly used imaging modality for craniopharyngioma surveillance; however, it carries risks such as allergic reaction and gadolinium deposition. This study evaluates the efficacy of non-contrast enhanced MRI (NCMRI) with a balanced steady state free precession (bSSFP) sequence compared with CEMRI T1-weighted imaging for craniopharyngioma surveillance. MATERIALS AND METHODS: 29 craniopharyngioma patients (16 female/13 male, mean age=21.5± 4.3 years) with CEMRIs including a bSSFP sequence were evaluated. For each patient, 2 blinded neuroradiologists compared the dimensions of residual craniopharyngioma on noncontrast and contrast-enhanced sequences. Tumor volume and solid/cystic component measurements were evaluated using paired t-tests. Diagnostic confidence levels for NC-and CE evaluations were measured using a 3-point scale (2=confident,1=adequate,0=unsure). Analyses of tumor involvement of cranial nerves and adjacent vasculature and diagnostic confidence were performed using Fisher’s exact and chi-square tests. RESULTS: No significant difference was observed between residual tumor volumes in both studies (18.86±21.67 cm3 vs 17.64±23.85 cm3, p=0.55) and measurements of dominant solid component volume, number of cystic components, and largest cystic component volume (2.71±3.47 cm3 vs 3.95±5.51 cm3, p=0.10; 2.5±1.5 vs 2.9±1.5, p=0.10; 7.61±13.41 vs 6.84±13.37 cm3, p=0.22, respectively). Tumoral involvement of cranial nerves II (p=0.64), III (p=0.42), and adjacent vasculature (p=0.05) showed no significant differences in detection. Diagnostic confidence was comparable evaluating cranial nerve II, vascular structures, and third ventricle (p>0.05) involvement. Higher levels of confidence were observed with bSSFP sequences for detection of cranial nerve III involvement (p=0.0001) and with ce-T1W for cavernous sinus involvement (p=0.02). CONCLUSIONS: NCMRI techniques using a bSSFP sequence provides similar characterization of craniopharyngiomas as contrast enhanced techniques. ABBREVIATIONS: 3D DRIVE, 3-dimensional driven equilibrium; ACA, anterior cerebral artery; bSSFP, balanced steady-state free precession; ce-T1W, contrast-enhanced T1-weighted imaging; CN, cranial nerve; GTR, gross total resection; STR, subtotal resection


  • Improving Workflow Efficiency at an Outpatient MRI Imaging Facility: A Case Study

    by Min Lang, Wei-Ching Lo, Andrew Sharp, Sean P. Hartmann, Oleg S. Pianykh, Lauren M. Melski, Jeremy A. Herrington, Robert Sellers, Vibhas Deshpande, Bryan Clifford, et al.


  • Medical Extended Reality for Radiology Education and Training

    by Min Lang, Samir Ghandour, Blaire Rikard, Eleni K. Balasalle, Mohammad R. Rouhezamin, Haipeng Zhang, Raul N. Uppot


  • Open Access

    Clinical Evaluation of a 2-Minute Ultrafast Brain MR Protocol for Evaluation of Acute Pathology in the Emergency and Inpatient Settings

    by Min Lang, Bryan Clifford, Wei-Ching Lo, Brooks P. Applewhite, Azadeh Tabari, Augusto Lio M. Goncalves Filho, Zahra Hosseini, Maria Gabriela Figueiro Longo, Stephen F. Cauley, Kawin Setsompop, et al.

    BACKGROUND AND PURPOSE: The use of MR imaging in emergency settings has been limited by availability, long scan times, and sensitivity to motion. This study assessed the diagnostic performance of an ultrafast brain MR imaging protocol for evaluation of acute intracranial pathology in the emergency department and inpatient settings. MATERIALS AND METHODS: Sixty-six adult patients who underwent brain MR imaging in the emergency department and inpatient settings were included in the study. All patients underwent both the reference and the ultrafast brain MR protocols. Both brain MR imaging protocols consisted of T1-weighted, T2/T2*-weighted, FLAIR, and DWI sequences. The ultrafast MR images were reconstructed by using a machine-learning assisted framework. All images were reviewed by 2 blinded neuroradiologists. RESULTS: The average acquisition time was 2.1 minutes for the ultrafast brain MR protocol and 10 minutes for the reference brain MR protocol. There was 98.5% agreement on the main clinical diagnosis between the 2 protocols. In head-to-head comparison, the reference protocol was preferred in terms of image noise and geometric distortion (P < .05 for both). The ultrafast ms-EPI protocol was preferred over the reference protocol in terms of reduced motion artifacts (P < .01). Overall diagnostic quality was not significantly different between the 2 protocols (P > .05). CONCLUSIONS: The ultrafast brain MR imaging protocol provides high accuracy for evaluating acute pathology while only requiring a fraction of the scan time. Although there was greater image noise and geometric distortion on the ultrafast brain MR protocol images, there was significant reduction in motion artifacts with similar overall diagnostic quality between the 2 protocols.


  • Telehealth and Virtual Reality Technologies in Chronic Pain Management: A Narrative Review

    by Ivo H. Cerda, Alexandra Therond, Sacha Moreau, Kachina Studer, Aleksy R. Donjow, Jason E. Crowther, Maria Emilia Mazzolenis, Min Lang, Reda Tolba, Christopher Gilligan, et al.

    Purpose of Review This review provides medical practitioners with an overview of the present and emergent roles of telehealth and associated virtual reality (VR) applications in chronic pain (CP) management, particularly in the post-COVID-19 healthcare landscape. Recent Findings Accumulated evidence points to the efficacy of now well-established telehealth modalities, such as videoconferencing, short messaging service (SMS), and mobile health (mHealth) applications in complementing remote CP care. More recently, and although still in early phases of clinical implementation, a wide range of VR-based interventions have demonstrated potential for improving the asynchronous remote management of CP. Additionally, VR-associated technologies at the leading edge of science and engineering, such as VR-assisted biofeedback, haptic technology, high-definition three-dimensional (HD3D) conferencing, VR-enabled interactions in a Metaverse, and the use of wearable monitoring devices, herald a new era for remote, synchronous patient-physician interactions. These advancements hold the potential to facilitate remote physical examinations, personalized remote care, and innovative interventions such as ultra-realistic biofeedback. Despite the promise of VR-associated technologies, several limitations remain, including the paucity of robust long-term effectiveness data, heterogeneity of reported pain-related outcomes, challenges with scalability and insurance coverage, and demographic-specific barriers to patient acceptability. Future research efforts should be directed toward mitigating these limitations to facilitate the integration of telehealth-associated VR into the conventional management of CP. Summary Despite ongoing barriers to widespread adoption, recent evidence suggests that VR-based interventions hold an increasing potential to complement and enhance the remote delivery of CP care.